[3 questions about gastrointestinal risk. Are coxibs here clearly better than NSAID?]].

Krüger, Klaus

[3 questions about gastrointestinal risk. Are coxibs here clearly better than NSAID?]]. [electronic resource] - MMW Fortschritte der Medizin Nov 2006 - 12 p. digital

Publication Type: Comparative Study; Interview

1438-3276


Anti-Inflammatory Agents, Non-Steroidal--adverse effects
Arthritis, Rheumatoid--drug therapy
Cardiovascular Diseases--chemically induced
Cyclooxygenase 2 Inhibitors--administration & dosage
Diclofenac--adverse effects
Etoricoxib
Humans
Osteoarthritis--drug therapy
Peptic Ulcer--chemically induced
Prospective Studies
Pyridines--adverse effects
Randomized Controlled Trials as Topic
Risk
Sulfones--adverse effects